Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Dummer, Reinhard  [Clear All Filters]
2022
He M, Soni B, Schwalie PC, Hüsser T, Waltzinger C, De Silva D, Prinz Y, Krümpelmann L, Calabro S, Matos I, et al. Combinations of Toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. J Immunother Cancer. 2022;10(6).
2020
Brüggen M-C, Valencak J, Stranzenbach R, Li N, Stadler R, Jonak C, Bauer W, Porkert S, Blaschke A, Meiss F, et al. Clinical diversity and treatment approaches to blastic plasmacytoid dendritic cell neoplasm: a retrospective multicentre study. J Eur Acad Dermatol Venereol. 2020.
2019
Ramelyte E, Dummer R, Guenova E. Investigative drugs for the treatment of cutaneous T-cell lymphomas (CTCL): an update. Expert Opin Investig Drugs. 2019.
Varum S, Baggiolini A, Zurkirchen L, Atak ZKalender, Cantù C, Marzorati E, Bossart R, Wouters J, Häusel J, Tuncer E, et al. Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma Formation. Cell Stem Cell. 2019;24(4):637-653.e9.
2015
DeSimone JA, Sodha P, Ignatova D, Dummer R, Cozzio A, Guenova E. Recent advances in primary cutaneous T-cell lymphoma. Curr Opin Oncol. 2015.
2014
Mehra T, Ikenberg K, Moos RMaria, Benz R, Nair G, Schanz U, Haralambieva E, Hoetzenecker W, Dummer R, French LEinar, et al. Brentuximab as a Treatment for CD30+ Mycosis Fungoides and Sézary Syndrome. JAMA Dermatol. 2014.